ceftazidime
Pneumonia
Beijing Tiantan HospitalSmall moleculePhase 4 / ApprovedActive
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Pneumonia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Linezolid University Ghent | Phase 4 | BB |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Denver Health and Hospital Authority | Phase 4 | BB |
CHLORHEXIDINE Beijing Tiantan Hospital | Phase 4 | BB |
NORMAL HUMAN SERUM ALBUMIN EASL - CLIF Consortium | Phase 4 | BB |
FLUDROCORTISONE Nantes University Hospital | Phase 3 | BB |
View all 20 →
Same molecule, other indications
ceftazidime is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →